PROFOUND MEDICAL CORP. (PROF) ROE
- 2026-06-30: ROE -65.74%.
- 2026-03-31: ROE -65.46%.
- 2025-12-31: ROE -64.08%.
- 2025-09-30: ROE -122.40%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -65.74% |
| 2026-03-31 | -65.46% |
| 2025-12-31 | -64.08% |
| 2025-09-30 | -122.40% |
| 2025-06-30 | -103.75% |
| 2025-03-31 | -62.92% |
| 2024-12-31 | -46.04% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -64.08% |
| 2024-12-31 | -46.04% |
| 2023-12-31 | -90.71% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |